PCOS and Weight Loss: How GLP-1 Breaks the Cycle
Insulin resistance drives PCOS weight gain — and GLP-1 medications directly target insulin signalling. Here's the clinical evidence and what to expect.
Dr. Anjali Patel
ALTRcare Medical Team
PCOS, Insulin Resistance, and GLP-1
PCOS affects 1 in 5 women in India and is the leading cause of infertility. Most PCOS patients struggle with weight loss because of the underlying insulin resistance — not lack of willpower.
The PCOS-Insulin Connection
PCOS causes irregular ovulation and excess androgens (male hormones). The root cause in most cases is insulin resistance. High insulin levels trigger fat storage, hunger hormones spike, and weight loss becomes nearly impossible through diet alone.
Why GLP-1 Works for PCOS
GLP-1 medications improve insulin sensitivity directly. This means:
- Lower insulin levels → Less fat storage
- Restored hunger hormones → Natural portion control
- Better ovulation → Potential fertility improvements
- Reduced inflammation → Acne and hirsutism may improve
Clinical Evidence
Studies show PCOS patients on GLP-1 therapy lose 12–20% of body weight AND report improved menstrual regularity and reduced androgen levels. The combination of weight loss + hormonal rebalancing is powerful.
Ready to take action?
Start your personalized weight loss plan with a free doctor consultation.